Patel Sanj K

US insider· US
Sign in for alerts
  • REDUCEDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    −15,144 sh · $1.2M

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +6,237 sh

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +6,237 sh

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +9,991 sh

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +6,481 sh

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +8,609 sh

    Filed 3 Sept 2026SEC Form 4view source
  • REDUCEDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    −15,144 sh · $1.2M

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +8,609 sh

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +6,481 sh

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Kiniksa Pharmaceuticals Intl · NASDAQ

    +9,991 sh

    Filed 3 Sept 2026SEC Form 4view source